We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LENZ market cap is 740.08M. The company's latest EPS is USD -1.8070 and P/E is -14.88.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.56M | -16.09M | -14.35M | -12.95M | -15.23M |
| Net Income | -22.92M | -16.65M | -10.25M | -10.22M | -12.65M |
| Year End 31 December 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -60.44M | -105.64M | -135.19M | -58.61M |
| Net Income | -70.76M | -101.05M | -124.65M | -49.77M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 188.46M | 217.32M | 202.64M | 224.01M | 215.3M |
| Total Liabilities | 4.87M | 19.16M | 9.72M | 8.73M | 11.22M |
| Total Equity | 183.58M | 198.17M | 192.92M | 215.28M | 204.08M |
| Year End 31 December 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 401.99M | 321.9M | 188.46M | 215.3M |
| Total Liabilities | 17.94M | 25.61M | 4.87M | 11.22M |
| Total Equity | 384.05M | 296.29M | 183.58M | 204.08M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -90.01M | -23.94M | -39.73M | -50.31M | -59.39M |
| Investing | 226.35M | 18M | -80.39M | -142.62M | -154.48M |
| Financing | 190k | 171.27M | 169.13M | 198.95M | 199M |
| Year End 31 December 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.85M | -87.98M | -90.01M | -59.39M |
| Investing | -5.74M | -241.86M | 226.35M | -154.48M |
| Financing | 417.47M | 597k | 190k | 199M |
| Market Cap | 740.08M |
| Price to Earnings Ratio | -14.88 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 36.74 |
| Price to Book Ratio | 3.63 |
| Dividend Yield | - |
| Shares Outstanding | 27.54M |
| Average Volume (1 week) | 317.35k |
| Average Volume (1 Month) | 326.16k |
| 52 Week Change | 69.21% |
| 52 Week High | 38.93 |
| 52 Week Low | 14.42 |
| Spread (Intraday) | 2.77 (9.34%) |
| Company Name | LENZ Therapeutics Inc |
| Address |
1201 north market st wilmington, delaware 19801 |
| Website | https://www.lenz-tx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
